相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Homologous recombination repair is essential for repair of vosaroxin-induced DNA double-strand breaks
Oncotarget (2015)
AKT1/BRCA1 in the control of homologous recombination and genetic stability: the missing link between hereditary and sporadic breast cancers
Oncotarget (2015)
Ubiquitin-activating enzyme UBA1 is required for cellular response to DNA damage
Pavel Moudry et al.
CELL CYCLE (2012)
The DNA damage response and cancer therapy
Christopher J. Lord et al.
NATURE (2012)
The role of PARP in DNA repair and its therapeutic exploitation
M. Javle et al.
BRITISH JOURNAL OF CANCER (2011)
Chk2 deficiency in Myc overexpressing lymphoma cells elicits a synergistic lethal response in combination with PARP inhibition
Andreas Hoglund et al.
CELL CYCLE (2011)
Poly(ADP-ribose) polymerase inhibition enhances p53-dependent and -independent DNA damage responses induced by DNA damaging agent
Diana Nguyen et al.
CELL CYCLE (2011)
Senescence-associated heterochromatin foci are dispensable for cellular senescence, occur in a cell type- and insult-dependent manner, and follow expression of p16ink4a
Martin Kosar et al.
CELL CYCLE (2011)
Synthetic lethality of PARP inhibition in cancers lacking BRCA1 and BRCA2 mutations
Konstantin J. Dedes et al.
CELL CYCLE (2011)
Studying Therapy Response and Resistance in Mouse Models for BRCA1-Deficient Breast Cancer
Ewa Malgorzata Michalak et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2011)
The underlying mechanism for the PARP and BRCA synthetic lethality: Clearing up the misunderstandings
Thomas Helleday
MOLECULAR ONCOLOGY (2011)
More than just a focus: The chromatin response to DNA damage and its role in genome integrity maintenance
Jiri Lukas et al.
NATURE CELL BIOLOGY (2011)
Poly(ADP-Ribose) Polymerase Is Hyperactivated in Homologous Recombination-Defective Cells
Ponnari Gottipati et al.
CANCER RESEARCH (2010)
53BP1 Inhibits Homologous Recombination in Brca1-Deficient Cells by Blocking Resection of DNA Breaks
Samuel F. Bunting et al.
CELL (2010)
Racing to block tumorigenesis after pRb loss An innocuous point mutation wins with synthetic lethality
Frederick Bauzon et al.
CELL CYCLE (2010)
Regulation of the PML tumor suppressor in drug-induced senescence of human normal and cancer cells by JAK/STAT-mediated signaling
Sona Hubackova et al.
CELL CYCLE (2010)
A Marker of Homologous Recombination Predicts Pathologic Complete Response to Neoadjuvant Chemotherapy in Primary Breast Cancer
Monika Graeser et al.
CLINICAL CANCER RESEARCH (2010)
Development of a Functional Assay for Homologous Recombination Status in Primary Cultures of Epithelial Ovarian Tumor and Correlation with Sensitivity to Poly(ADP-Ribose) Polymerase Inhibitors
Asima Mukhopadhyay et al.
CLINICAL CANCER RESEARCH (2010)
53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers
Peter Bouwman et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2010)
Poly(ADP-Ribose) Polymerase-1 Inhibitor Treatment Regresses Autochthonous Brca2/p53-Mutant Mammary Tumors In vivo and Delays Tumor Relapse in Combination with Carboplatin
Trevor Hay et al.
CANCER RESEARCH (2009)
In vitro assays for the evaluation of drug resistance in tumor cells
Jozef Hatok et al.
CLINICAL AND EXPERIMENTAL MEDICINE (2009)
The DNA-damage response in human biology and disease
Stephen P. Jackson et al.
NATURE (2009)
Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers.
Peter C. Fong et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
A high-throughput RNA interference screen for DNA repair determinants of PARP inhibitor sensitivity
Christopher J. Lord et al.
DNA REPAIR (2008)
A mutant allele of MRE11 found in mismatch repair-deficient tumor cells suppresses the cellular response to DNA replication fork stress in a dominant negative manner
Qin Wen et al.
MOLECULAR BIOLOGY OF THE CELL (2008)
Aberrations of the MRE11-RAD50-NBS1 DNA damage sensor complex in human breast cancer: MRE11 as a candidate familial cancer-predisposing gene
Jirina Bartkova et al.
MOLECULAR ONCOLOGY (2008)
Proteome-wide identification of poly(ADP-ribose) binding proteins and poly(ADP-ribose)-associated protein complexes
Jean-Philippe Gagne et al.
NUCLEIC ACIDS RESEARCH (2008)
High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugs
Sven Rottenberg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
PARP1-dependent kinetics of recruitment of MRE11 and NBS1 proteins to multiple DNA damage sites
Jean-Francois Haince et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Targeted cancer therapies based on the inhibition of DNA strand break repair
M. J. O'Connor et al.
ONCOGENE (2007)
DNA damage response mediators MDC1 and 53BP1:: constitutive activation and aberrant loss in breast and lung cancer, but not in testicular germ cell tumours
J. Bartkova et al.
ONCOGENE (2007)
Breast cancer risk is associated with the genes encoding the DNA double-strand break repair Mre11/Rad50/Nbs1 complex
Huan-Ming Hsu et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
Mre11-Rad50-Nbs1 is a keystone complex connecting DNA repair machinery, double-strand break signaling, and the chromatin template
R. Scott Williams et al.
BIOCHEMISTRY AND CELL BIOLOGY (2007)
Deficiency in the repair of DNA damage by homologous recombination and sensitivity to poly(ADP-ribose) polymerase inhibition
Nuala McCabe et al.
CANCER RESEARCH (2006)
Inhibition of poly(ADP-ribose) pollyrnerase in cancer
Elizabeth Ruth Plummer
CURRENT OPINION IN PHARMACOLOGY (2006)
Poly(ADP-ribose):: novel functions for an old molecule
Valerie Schreiber et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
BRCA2-deficient CAPAN-1 cells are extremely sensitive to the inhibition of poly (ADP-Ribose) polymerase
N McCabe et al.
CANCER BIOLOGY & THERAPY (2005)
Absence of specific cell killing of the BRCA2-deficient human cancer cell line CAPAN1 by poly(ADP-ribose) polymerase inhibition
E Gallmeier et al.
CANCER BIOLOGY & THERAPY (2005)
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
J Bartkova et al.
NATURE (2005)
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
HE Bryant et al.
NATURE (2005)
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
H Farmer et al.
NATURE (2005)
Distinct functional domains of Nbs1 modulate the timing and magnitude of ATM activation after low doses of ionizing radiation
Z Horejsí et al.
ONCOGENE (2004)
In vitro assays of tumor chemosensitivity and chemoresistance
U Testa et al.
DRUGS OF THE FUTURE (2004)
Human MRE11 is inactivated in mismatch repair-deficient cancers
G Giannini et al.
EMBO REPORTS (2002)
Genome maintenance mechanisms for preventing cancer
JHJ Hoeijmakers
NATURE (2001)
Differential effects of the poly (ADP-ribose) polymerase (PARP) inhibitor NU1025 on topoisomerase I and II inhibitor cytotoxicity in L1210 cells in vitro
KJ Bowman et al.
BRITISH JOURNAL OF CANCER (2001)
In vitro preclinical models for a rational design of chemotherapy combinations in human tumors
W Zoli et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2001)
分享论文
